DR. RAPHAEL CLYNES, M.D.
Hospitals at 168 St, New York, NY
License number
New York 190259-1
Category
Hospitals
Type
General Acute Care Hospital
Address
Address
630 W 168Th St P&S 8-510, New York, NY 10032
Phone
(212) 305-5289
(212) 305-1392 (Fax)
(212) 305-1392 (Fax)
Personal information
See more information about RAPHAEL CLYNES at radaris.comName
Address
Phone
231 Van Houten Flds, West Nyack, NY 10994
Nyack, NY
231 Van Houten Flds, West Nyack, NY 10994
504 63Rd St, New York, NY 10021
1233 York Ave, New York, NY 10021
Professional information
Associate Professor At Columbia University
Position:
Associate Professor at Columbia University
Location:
Greater New York City Area
Industry:
Medical Practice
Work:
Columbia University
-
Associate Professor
Memorial Sloan-Kettering Cancer Center
1992 - 1999
-
Clinical Instructor/Research Associate
Education:
State University of New York at Stony Brook 1983 - 1990
M.D., Ph.D., Medicine and Biochemistry Massachusetts Institute of Technology 1976 - 1983
B.S., Biology
M.D., Ph.D., Medicine and Biochemistry Massachusetts Institute of Technology 1976 - 1983
B.S., Biology
Raphael Aloys Clynes, New York NY
Specialties:
Critical Care Specialist
Address:
630 W 168Th St, New York, NY 10032
622 W 168Th St, New York, NY 10032
622 W 168Th St, New York, NY 10032
Education:
State University of New York, School of Medicine (Stony Brook) - Doctor of Medicine
State University of New York (Stony Brook) - Doctor of Philosophy
Barnes-Jewish Hospital - Fellowship - Hematology and Oncology (Internal Medicine)
State University of New York (Stony Brook) - Doctor of Philosophy
Barnes-Jewish Hospital - Fellowship - Hematology and Oncology (Internal Medicine)
Board certifications:
American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine), American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Dr. Raphael A Clynes, New York NY - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
622 W 168Th St, New York 10032
(212) 305-5289 (Phone), (212) 305-1392 (Fax)
NEW YORK PRESBYTERIAN HOSPITAL
622 W 168Th St, New York 10032
(212) 746-3600 (Phone), (212) 342-2717 (Fax)
SMOKING CESSATION CLINIC
1051 Riverside Dr SUITE 98, New York 10032
(212) 543-5741 (Phone), (212) 543-5607 (Fax)
(212) 305-5289 (Phone), (212) 305-1392 (Fax)
NEW YORK PRESBYTERIAN HOSPITAL
622 W 168Th St, New York 10032
(212) 746-3600 (Phone), (212) 342-2717 (Fax)
SMOKING CESSATION CLINIC
1051 Riverside Dr SUITE 98, New York 10032
(212) 543-5741 (Phone), (212) 543-5607 (Fax)
Certifications:
Hematology, 2011, Internal Medicine, 1994, Medical Oncology, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
State University of New York / Health Science Center At Stony Brook
Graduated: 1990
Barnes Hosp/Wash U
State University of New York / Health Science Center At Stony Brook
Graduated: 1990
Barnes Hosp/Wash U
Mice Mutant For Functional Fc Receptors And Method Of Treating Autoimmune Diseases
US Patent:
5877396, Mar 2, 1999
Filed:
Aug 18, 1994
Appl. No.:
8/292569
Inventors:
Jeffrey V. Ravetch - New York NY
Toshiyuki Takai - Okayama, JP
Diana Sylvestre - New York NY
Raphael Clynes - New York NY
Toshiyuki Takai - Okayama, JP
Diana Sylvestre - New York NY
Raphael Clynes - New York NY
Assignee:
Sloan Kettering Institute for Cancer Research - New York NY
International Classification:
A61K 4900, C12N 1500, G01N 3100
US Classification:
800 2
Abstract:
Disclosed herein is a non-naturally occurring non-human vertebrate animal incapable of expressing a functional Fc receptor which may optionally be capable of expressing a protein which comprises a domain of a human Fc receptor, as well as DNA encoding such Fc receptor-based proteins. Also disclosed are in vivo methods for identifying proinflammatory agents that depend on a functional Fc receptor, in vivo methods for identifying proinflammatory agents that do not depend on a functional Fc receptor, and both in vivo and in vitro methods of identifying anti-inflammatory agents. Pharmaceutical compositions containing, and methods of treating inflammation with anti-inflammatory agents are also described.